Quipu, Hercules, Serpens–Corona Borealis and Sculptor–Pegasus are all larger than the fifth and final superstructure ...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.

Boehringer Ingelheim’s lung disease drug nerandomilast has been successful in a Phase III study paving the way for the ...

Amazon Health Services offers you curated choices, convenience, clarity of cost, and continuity of care on your path to get and stay healthy.

Besides the $750 million fixed-rate senior notes, Elanco bears floating interest rates on $3.8 billion in loans and credits. In response to the high-interest-rate environment in recent years, the ...

Nerandomilast, an oral phosphodiesterase 4B inhibitor, hit the primary endpoint in a Phase III trial in progressive pulmonary ...

FIBRONEER™-ILD was a double-blind, randomized, placebo-controlled trial evaluating the efficacy and safety of nerandomilast ...

Topline data from FIBRONEER-ILD show that the investigational compound nerandomilast met its primary endpoint, which was the absolute change from baseline in forced vital capacity [mL] at week 52 vers ...

Boehringer Ingelheim India and EMRI Green Health Services a GVK Enterprise Sign MoU to Transform Pre-hospital Stroke Care in India ...

The tiny bits of plastic pollution that make their way from the environment into our bodies accumulate at much higher ...